Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

The condition mostly affects those from African and Caribbean backgrounds but Victoria Ekanoye says it can affect anyone. | ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...

The Executive Director of the Ghana Foundation for Sickle Gene Action, Victoria Awo Twumasi, has called on President John Dramani Mahama to include full coverage of sickle cell disease treatment under ...

A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...

The global sickle cell disease treatment market is poised for significant growth, driven by the increasing prevalence of the disease and the demand for effective treatments. North America, led by the ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

By Deslyn a Joseph Patients afflicted with sickle cell disease gathered outside the Prime Minister's Office yesterday to ...

In a sharply divided political climate, San Rocco Therapeutics (SRT) has done what few thought possible—earned support from both the highest levels of Washington and from those who distrust it.